All In MedTech

FDA Clearance Tracker · P170039-S002

CustomFlex Artificial Iris

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 3, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 3, 2019

Approved

Time to decision

441 days

Received Jul 19, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P170039-S002
Device name
CustomFlex Artificial Iris
Applicant location
Erlangen
Received
Jul 19, 2018
Decided
Oct 3, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P170039

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code QBT

FDA's approval statement

As written in FDA's record.

Approval of the protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for Humanoptics AG

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.